Nucleic acid therapeutics in neurodegenerative disorders: emerging technologies and clinical landscape
Nov 09, 2026
In this review, we summarize recent advances in nucleic acid therapeutics, including ASOs, siRNAs, and aptamers, for neurodegenerative disorders such as ALS and Alzheimer’s disease. We discuss chemical engineering, emerging delivery strategies, ongoing clinical trials, and future perspectives for central nervous system targeting.